Injection of a staphylococcal superantigen (SAg) such as staphylococcal ent
erotoxin B (SEE) in adult mice results in cytokine production and cell prol
iferation which can lead to septic shock. The aim of the present work was t
o identify the cytokines and co-stimulatory molecules regulating the in viv
o systemic release of IFN-gamma, a cytokine known to play an important role
in the pathophysiology associated with bacterial infections. We demonstrat
e in this study that (i) in contrast to lipopolysaccharide (LPS), SEE admin
istration induces high levels of the p70, bioactive form, of IL-12; (ii) IL
-12 production in response to SEE requires both CD40-dependent signals and
IFN-gamma secretion; (iii) the early systemic release of IFN-gamma (3 h pos
t-treatment) in response to SEE is IL-12 independent, while the sustained,
late response (6-9 h post-treatment) requires endogenous IL-12 production;
(iv) IL-12 produced during the primary SEE response (day 0) is responsible
for priming cells in vive to high IFN-gamma production upon secondary chall
enge (day 2); (v) the priming effect of IL-12 is TCR unrelated, as SEE-prim
ed animals secrete high levels of IFN-gamma in response to both staphylococ
cal enterotoxin A and LPS administered 48 h later, The ability of bacterial
SAg to induce septic shock and to modulate the immune response to unrelate
d antigens may therefore be related to their unique capacity to induce syst
emic IL-12 production in vive. These observations also help to explain why
SEE-primed animals, known to express an anergic phenotype 48 h post-treatme
nt (as judged by defective IL-2 production and proliferation), nevertheless
display an increased capacity to secrete the inflammatory cytokine IFN-gam
ma.